Clin Mol Hepatol.
2024 Oct;30(4):718-720. 10.3350/cmh.2024.0519.
Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”
- Affiliations
-
- 1Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea
- 2Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- KMID: 2560079
- DOI: http://doi.org/10.3350/cmh.2024.0519
